Compare Aspen Aerogels Inc (ASPN) vs Goldman Sachs Group Inc (GS) Price & Performance

ASPN trades at $5.16, down 1.53% on the day, with a bearish technical signal despite oversold RSI readings. The company reported a Q1 2026 loss of $0.28 per share, missing estimates, but revenue beat expectations. Recent news includes a 2025 Supplier of the Year award from General Motors and the staged restart of its East Providence facility. Financials show significant net losses but improving cash flow trends into 2026.

Outlook remains challenging with persistent losses and negative margins, though analyst consensus is strongly bullish (83% buy ratings). Key risks include execution on facility restarts and EV demand volatility. The stock offers high-risk growth potential if operational improvements and electrification trends accelerate profitability.

Goldman Sachs (GS) trades at $1,055.18, down 0.07% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $17.55 surpassing expectations of $16.47. Revenue grew to $58.28 billion in 2025, and net income margin improved to 29.89%. Recent news highlights GS's role in leading high-profile IPOs like Anthropic, signaling robust investment banking activity. The stock is near its pivot point of $1,055, with support at $1,045 and resistance at $1,065.

The outlook for GS is positive, driven by earnings momentum and a favorable IPO pipeline, but risks include volatile cash flows and macroeconomic sensitivity. Analyst consensus is a Buy with a price target of $1,080, indicating potential upside. Investors should monitor execution in investment banking and market conditions.